The National Patient Safety Office has commenced a scoping exercise to establish a national patient safety surveillance system. This will provide evidence to inform patient safety policy and leadership decisions, bringing data from many sources together to inform prioritisation and monitoring of implementation.
This creates the opportunity to address the ‘precursors to harm, and not just the harm itself’ and helps to develop a ‘problem sensing’ culture that actively seeks patient safety alerts.
A surveillance system is likely to include (but is not limited to):
The collection of data is not an endpoint and it is important that the surveillance of patient safety profiles for patients, service and clinical cohorts is part of the quality improvement cyclical process. It will also assist in identifying and developing processes to address data gaps of importance.
The Committee of the National Healthcare Quality Reporting System publishes an annual report on selected indicators of health service performance and outcomes. The focus is on reporting a balanced set of healthcare data that gives an overview of how our health services are performing.
It is intended that the National Healthcare Quality Reporting System will evolve over time to include new indicators and to respond to changing priorities. Each report and the infographic summary (where available) can be accessed by clicking the link below.
Antimicrobials are medicines used to treat infections or disease, and are essential in both human and animal health.
Antimicrobial resistance occurs when an antimicrobial that was previously effective, is no longer effective to treat an infection or disease caused by a microorganism.
The development of resistance is a natural phenomenon that will inevitably occur when antimicrobials are used to treat disease. The problem at present is that the sheer volume of antimicrobials being used globally in humans, animals and in other situations is leading to significant increases in the rate of development of resistance with the result that common infections are becoming more difficult to treat and microorganisms that are resistant to many antimicrobials, so called ‘superbugs’, are emerging.
Whilst the term antimicrobial resistance is used throughout this document, much of the detail and the activities in this, Ireland's first national action plan on AMR, are focused specifically on antibiotic resistance. The Plan was jointly published with the Department of Agriculture, Food and the Marine and you can access their AMR webpage here.
Visit the HSE Healthcare Associated Infection & Antimicrobial Resistance page.
Further information is available on antimicrobial resistance.
The Department of Health is pleased to be involved with the National Patient Experience Survey. This nationwide survey, which commenced in 2017, will ask patients about their recent experience in hospital in order to inform and guide quality improvement initiatives for the health service at a local and national level. The department is committed to initiatives of this kind which will allow the health service to capture learning from its patients that in turn inform improvements to the quality and safety of that service.
A number of Patient Safety Reports and working documents have been published in Ireland. These provide significant learning in relation to patient safety. In addition, the reports have a number of recommendations for implementation by various bodies.
You can access National Patient Safety Reports below: